LYPLA2 and neoplasm: The most prominent characteristic of an aggressive tumor phenotype was the enhanced activity of palmitoyl protein hydrolases (ABHD12, LYPLA2 and ABHD10)17 associated with a large number of S-palmitoylated proteins within discriminative signature (Fig. 5e).